Patents by Inventor Frank Hans Seiler

Frank Hans Seiler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Pharmaceutical Composition Comprising PI3K-Inhibitor
    Publication number: 20170209455
    Abstract: The application relates to solid pharmaceutical compositions suitable for oral administration, processes for their production and uses of the pharmaceutical compositions.
    Type: Application
    Filed: July 24, 2015
    Publication date: July 27, 2017
    Applicant: Novartis AG
    Inventors: Dipen Desai, Bruno Galli, Rakesh Patel, Manuel Vincente Sanchez-Felix, Frank Hans Seiler, Navnit H. Shah, Daya D. Verma, Toni Widmer, Stefanie Meyer, Raman Iyer, Severine Serreau, Simone Grandolini, Oliver Graner
  • Oxazolidin-2-one compounds and uses thereof
    Patent number: 9458177
    Abstract: The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: October 4, 2016
    Assignee: NOVARTIS AG
    Inventors: Giorgio Caravatti, Robin Alec Fairhurst, Pascal Furet, Clive McCarthy, Heinrich Rueeger, Frank Hans Seiler, Frédéric Stauffer
  • OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF
    Publication number: 20140378450
    Abstract: The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Applicant: Novartis AG
    Inventors: Giorgio CARAVATTI, Robin Alec FAIRHURST, Pascal FURET, Clive MCCARTHY, Heinrich RUEEGER, Frank Hans SEILER, Frédéric STAUFFER
  • Oxazolidin-2-one compounds and uses thereof
    Patent number: 8865894
    Abstract: The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: October 21, 2014
    Assignee: Novartis AG
    Inventors: Giorgio Caravatti, Robin Alec Fairhurst, Pascal Furet, Frédéric Stauffer, Frank Hans Seiler, Clive McCarthy, Heinrich Rueeger